Floatz logo

849 assets in Breast Cancer

Therapeutic assets addressing Breast Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
QXL138AM
Breast Cancer
Nammi Therapeutics IncP1C (36)
Recombinant Humanized Type Iii Collagen
Breast Cancer
Peking University People's HospitalP1C (36)
Rgt-419B
Breast Cancer
Regor Pharmaceuticals Inc.P1C (36)
Rgt-490
Breast Cancer
Regor Pharmaceuticals Inc.P1C (36)
Rimiducid
Breast Cancer
M.D. Anderson Cancer CenterP1C (36)
SAR443216
Breast Cancer
SanofiP1C (36)
Son-Dp
Breast Cancer
Qurgen Inc.P1C (36)
syn608
Breast Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdP1C (36)
syn818
Breast Cancer
Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdP1C (36)
sys6043
Breast Cancer
Conjupro Biotherapeutics, Inc.P1C (36)
tas2940
Breast Cancer
Taiho Oncology, Inc.P1C (36)
Tbio-4101
Breast Cancer
Turnstone Biologics, Corp.P1C (36)
Valemetostat
Breast Cancer
M.D. Anderson Cancer CenterP1C (36)
Vsv-02
Breast Cancer
The First Affiliated Hospital of Xinxiang Medical CollegeP1C (36)
sm-88
Breast Cancer
Tyme, IncP2C (34)
[177Lu]Lu-HT547
Breast Cancer
Hua PangEarly P1C (33)
68ga-dota-dpne
Breast Cancer
Peking Union Medical College HospitalEarly P1C (33)
[⁶⁸Ga]Ga-HT547
Breast Cancer
Hua PangEarly P1C (33)
68Ga-RGD
Breast Cancer
Peking Union Medical College HospitalEarly P1C (33)
68ga-rm26-rgd
Breast Cancer
Peking Union Medical College HospitalEarly P1C (33)
89zr-dfo-n-suc-c9scfv
Breast Cancer
Var2 PharmaceuticalsEarly P1C (33)
89Zr-DFO-N-Suc-F8scFv
Breast Cancer
Var2 PharmaceuticalsEarly P1C (33)
89zr-lncab072
Breast Cancer
Affiliated Hospital of Jiangnan UniversityEarly P1C (33)
89zr-lncab103
Breast Cancer
Affiliated Hospital of Jiangnan UniversityEarly P1C (33)
89zr-lncab104
Breast Cancer
Affiliated Hospital of Jiangnan UniversityEarly P1C (33)
89zr-lncab190
Breast Cancer
Affiliated Hospital of Jiangnan UniversityEarly P1C (33)
99mTc-MIRC213
Breast Cancer
Peking Union Medical College HospitalEarly P1C (33)
Dihydrotestosterone
Breast Cancer
Memorial Sloan Kettering Cancer CenterEarly P1C (33)
Hs-It101
Breast Cancer
The Affiliated Hospital of Qingdao UniversityEarly P1C (33)
inn805
Breast Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.Early P1C (33)
mb1707
Breast Cancer
Mainline Biosciences, Inc.Early P1C (33)
Mitazalimab
Breast Cancer
Jennifer ZhangEarly P1C (33)
R130
Breast Cancer
Shanghai Yunying Medical TechnologyEarly P1C (33)
Radgocitabine
Breast Cancer
Dana-Farber Cancer InstituteP1C (33)
Recombinant L-Ifn Adenovirus
Breast Cancer
Shanghai Fengxian District Central HospitalEarly P1C (33)
Coconut Oil
Breast Cancer
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalEarly P1C (32)
(1R,3R)-N<sup>1</sup>-[5-(1-Ethylpropyl)pyrazolo[1,5-a]pyrimidin-7-yl]-1,3-cyclopentanediamine
Breast Cancer
Nuvation Bio Inc.P1/2D (31)
Hucart-Meso Cells
Breast Cancer
University of PennsylvaniaP1D (31)
99mTc-ADAPT6
Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of SciencesN/AD (30)
[99mTc]Tc-G3-(G3S)3C
Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of SciencesN/AD (30)
Charcoal Activated
Breast Cancer
Fujian Medical University Union HospitalN/AD (30)
Magrolimab
Breast Cancer
National Cancer Institute (NCI)P1D (30)
Soluble Fluorescein
Breast Cancer
Mayo ClinicN/AD (30)
App-111
Breast Cancer
Veru Inc.P2D (29)
Tusamitamab Ravtansine
Breast Cancer
Erasmus Medical CenterP2D (29)
Benralizumab
Breast Cancer
Memorial Sloan Kettering Cancer CenterP2D (28)
[68ga]ga-ttp
Breast Cancer
Peking University Cancer Hospital & InstituteN/AD (26)
Showing 751 to 800 of 849 assets
PreviousPage 16 of 17Next